MoneyWorks4Me

ANVISA-Brazil concludes inspection at manufacturing facility of Caplin Point’s arm

17 Aug 2024 Evaluate

ANVISA-Brazil has completed inspection at Caplin Point Laboratories’ subsidiary -- Caplin Steriles’ injectable and ophthalmic manufacturing facility located at Gummidipoondi. The inspection was conducted between August 12 and 16, 2024 and concluded with zero observations.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..